Vasopressin's role as a
vasoconstrictor in chronic
heart failure, was examined in rabbits with
adriamycin cardiomyopathic
congestive heart failure. Chronic
adriamycin treatment resulted in a decrease in cardiac output (829 +/- 38-610 +/- 36 ml/min, P less than 0.005) and blood pressure (83 +/- 2-76 +/- 3 mmHg, P less than 0.01), and an increase in peripheral resistance (8,377 +/- 381-10,170 +/- 657 dyn-s-cm-5, P less than 0.05). Plasma
renin activity (4.7 +/- 0.6-10.9 +/- 2.8 ng
angiotensin I/ml X h) and
norepinephrine (0.7 +/- 0.1-1.3 +/- 0.2 pmol/ml, P less than 0.05) increased while plasma
vasopressin levels did not change.
Vasopressin infusion, however, produced significantly greater increases in peripheral resistance in animals with
heart failure than in controls. Moreover, a specific
vasopressin vascular antagonist reduced blood pressure (7 +/- 3%) and peripheral resistance (14 +/- 4%) and increased cardiac output (10 +/- 3%) in animals with
heart failure but had no cardiovascular effects in normal rabbits. These results suggest that vascular sensitivity to
vasopressin is increased in
heart failure, and that it contributes significantly to the increased afterload in
heart failure despite normal plasma levels. In this model of severe, chronic
heart failure the sympathetic,
renin-
angiotensin, and
vasopressin systems all appear to be activated.